Nu Skin expects Q4 revenue of $310M-$340M while advancing East-West operating model (NYSE:NUS)
Nu Skin Enterprises (NUS) reported Q3 2026 revenue of $311M and adjusted EPS of $0.10, within guidance. CEO Ryan Napierski noted ongoing pressures in the core business but highlighted strong performance from the Rhyz manufacturing platform. The company expects Q4 revenue between $310M-$340M. (NYSE: NUS)
How this was made
The 30-second read
Why it matters
The earnings release introduces fresh revenue figures and forward guidance, which can shift investor sentiment and affect the stock price.
Market read
First report of Q3 results and Q4 guidance for Nu Skin, providing actionable data for traders.
What to watch
Potential cost reductions or new product launches not disclosed could mitigate revenue concerns.
Background
Nu Skin Enterprises (NYSE:NUS) provides direct-selling health and beauty products. The company released its Q3 earnings and forward guidance.
Ticker impact
Nu Skin reported Q3 revenue of $311M and gave Q4 guidance of $310M-$340M, new earnings information.
potential downside as investors price in guidance shortfall
The disclosed Q4 revenue range is modest and could disappoint analysts, likely prompting a sell pressure.
Market effects
May affect other direct-selling consumer health companies as guidance signals sector demand.
Limited to U.S. listed consumer health sector.
Low global impact beyond niche sector.
Counterpoint
Guidance could be seen as stable, supporting a hold stance if expectations were higher.
Key entities
- CompanyNu Skin Enterprises
US-listed consumer health and beauty products company.
